Effective drug therapy for vitreoretinal disease is a major challenge in the field of
ophthalmology; various protective systems, including anatomical and physiological barriers …

Macular edema is the pathological accumulation of fluid in the central retina. It is a
complication of many retinal diseases, including diabetic retinopathy, retinal vascular …

Purpose Dual inhibition of angiopoietin-2 and VEGF-A with faricimab (Vabysmo) offers
excellent visual acuity gains with strong durability in patients with diabetic macular edema …

Retinal vein occlusion represents the second leading cause of retinal vascular disorders,
with a uniform sex distribution worldwide. A thorough evaluation of cardiovascular risk …

Background: To investigate whether vaccination against SARS-CoV-2 is associated with the
onset of retinal vascular occlusive disease (RVOD). Methods: In this multicentre study, data …

Anti-VEGF drugs are first-line treatments for retinal neovascular diseases, but these anti-
angiogenic agents may also aggravate retinal damage by inducing hypoxia. Mitophagy can …

Aim To evaluate the association between the value of neutrophil to lymphocyte ratio (NLR),
platelet to lymphocyte ratio (PLR), monocyte to high-density lipoprotein ratio (MHR) and the …

Purpose To analyze the 3-year outcomes in a broad population of patients starting VEGF
inhibitors for central retinal vein occlusion (CRVO) in routine clinical practice. Design …

Objective To analyze recent publications in Ophthalmology, the journal of the American
Academy of Ophthalmology. Design Retrospective review of published articles. Participants …

Objectives To identify whether the outcomes of neovascular age-related macular
degeneration (nAMD), diabetic macular oedema (DMO) and retinal vein occlusion (RVO) in …